Cargando…

MUC1 and MUC5AC implication in Tunisian colorectal cancer patients

BACKGROUND/AIM: Mucins, such as MUC1 and MUC5AC , are known for their protective and moisturizing role in intestinal epithelium. Their expression is tightly controlled given their essential role in normal tissue homeostasis, whereas their deregulation leads to chronic inflammation, and even cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: HAZGUI, Meriam, WESLATI, Marwa, BOUGHRIBA, Rahma, OUNISSI, Donia, BACHA, Dhouha, BOURAOUI, Saadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991860/
https://www.ncbi.nlm.nih.gov/pubmed/32967412
http://dx.doi.org/10.3906/sag-2003-29
_version_ 1783669257828040704
author HAZGUI, Meriam
WESLATI, Marwa
BOUGHRIBA, Rahma
OUNISSI, Donia
BACHA, Dhouha
BOURAOUI, Saadia
author_facet HAZGUI, Meriam
WESLATI, Marwa
BOUGHRIBA, Rahma
OUNISSI, Donia
BACHA, Dhouha
BOURAOUI, Saadia
author_sort HAZGUI, Meriam
collection PubMed
description BACKGROUND/AIM: Mucins, such as MUC1 and MUC5AC , are known for their protective and moisturizing role in intestinal epithelium. Their expression is tightly controlled given their essential role in normal tissue homeostasis, whereas their deregulation leads to chronic inflammation, and even cancer. This study aimed to assess the expression profiles of MUC1 and MUC5AC and their implications in colorectal carcinogenesis. MATERIALS AND METHODS: A retrospective study of 202 patients who underwent colorectal cancer (CRC) surgery was conducted. The expression of MUC1 and MUC5AC was investigated by immunohistochemistry and reverse-transcription polymerase chain reaction (RT-PCR). Statistical analysis of mucin expression pattern, as well as the clinicopathological criteria of the patients, was performed using the chi-square test, survival curves were plotted using the Kaplan—Meier product-limit method, and differences between the survival curves were tested using the log-rank test. RESULTS: The expression of both mucins was abnormally high in the tumor tissues for both mRNA and protein. MUC1 expression was correlated with advanced cancer stages and lymph node metastases for both the mRNA (P < 0.016 and P < 0.002, respectively) and protein level (P < 0.006 and P < 0.001, respectively). However, MUC5AC expression did not pinpoint any significant association between the clinicopathological criteria, but patients who expressed MUC5AC showed an increase in overall survival (P < 0.009). CONCLUSION: The expression of MUC1 might be a poor prognostic biomarker in CRC and could play a role in tumor transformation and metastasis. However, MUC5AC expression might be a good prognostic in the Tunisian cohort.
format Online
Article
Text
id pubmed-7991860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-79918602021-03-30 MUC1 and MUC5AC implication in Tunisian colorectal cancer patients HAZGUI, Meriam WESLATI, Marwa BOUGHRIBA, Rahma OUNISSI, Donia BACHA, Dhouha BOURAOUI, Saadia Turk J Med Sci Article BACKGROUND/AIM: Mucins, such as MUC1 and MUC5AC , are known for their protective and moisturizing role in intestinal epithelium. Their expression is tightly controlled given their essential role in normal tissue homeostasis, whereas their deregulation leads to chronic inflammation, and even cancer. This study aimed to assess the expression profiles of MUC1 and MUC5AC and their implications in colorectal carcinogenesis. MATERIALS AND METHODS: A retrospective study of 202 patients who underwent colorectal cancer (CRC) surgery was conducted. The expression of MUC1 and MUC5AC was investigated by immunohistochemistry and reverse-transcription polymerase chain reaction (RT-PCR). Statistical analysis of mucin expression pattern, as well as the clinicopathological criteria of the patients, was performed using the chi-square test, survival curves were plotted using the Kaplan—Meier product-limit method, and differences between the survival curves were tested using the log-rank test. RESULTS: The expression of both mucins was abnormally high in the tumor tissues for both mRNA and protein. MUC1 expression was correlated with advanced cancer stages and lymph node metastases for both the mRNA (P < 0.016 and P < 0.002, respectively) and protein level (P < 0.006 and P < 0.001, respectively). However, MUC5AC expression did not pinpoint any significant association between the clinicopathological criteria, but patients who expressed MUC5AC showed an increase in overall survival (P < 0.009). CONCLUSION: The expression of MUC1 might be a poor prognostic biomarker in CRC and could play a role in tumor transformation and metastasis. However, MUC5AC expression might be a good prognostic in the Tunisian cohort. The Scientific and Technological Research Council of Turkey 2021-02-26 /pmc/articles/PMC7991860/ /pubmed/32967412 http://dx.doi.org/10.3906/sag-2003-29 Text en Copyright © 2021 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
HAZGUI, Meriam
WESLATI, Marwa
BOUGHRIBA, Rahma
OUNISSI, Donia
BACHA, Dhouha
BOURAOUI, Saadia
MUC1 and MUC5AC implication in Tunisian colorectal cancer patients
title MUC1 and MUC5AC implication in Tunisian colorectal cancer patients
title_full MUC1 and MUC5AC implication in Tunisian colorectal cancer patients
title_fullStr MUC1 and MUC5AC implication in Tunisian colorectal cancer patients
title_full_unstemmed MUC1 and MUC5AC implication in Tunisian colorectal cancer patients
title_short MUC1 and MUC5AC implication in Tunisian colorectal cancer patients
title_sort muc1 and muc5ac implication in tunisian colorectal cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991860/
https://www.ncbi.nlm.nih.gov/pubmed/32967412
http://dx.doi.org/10.3906/sag-2003-29
work_keys_str_mv AT hazguimeriam muc1andmuc5acimplicationintunisiancolorectalcancerpatients
AT weslatimarwa muc1andmuc5acimplicationintunisiancolorectalcancerpatients
AT boughribarahma muc1andmuc5acimplicationintunisiancolorectalcancerpatients
AT ounissidonia muc1andmuc5acimplicationintunisiancolorectalcancerpatients
AT bachadhouha muc1andmuc5acimplicationintunisiancolorectalcancerpatients
AT bouraouisaadia muc1andmuc5acimplicationintunisiancolorectalcancerpatients